Ex-France international rugby player has Parkinson’s disease

News

Author: Geoffrey ChangPublished: 23 December 2015

Prep: Cook: Serves:

Ex-France international rugby player Marc Dal Maso has revealed he has Parkinson’s disease.

In his career, the 48-year-old played 33 times for France as a hooker between 1988 and 2000 and appeared in the 1999 World Cup as well as winning the Five Nations Grand Slam in 1997 and 1998. He was a coach for Japan at this year’s World Cup when the Asian team surprised everyone by beating South Africa.

Dal Maso says he decided to go public because of negative rumours that were spreading.

He told the Midi-Olympique rugby daily: “There were rumours doing the rounds so rather than listen to people say stupid things it was better that they know. Let’s just say there are sports which help illnesses like this and rugby is one of them.”

He added that the illness had been detected in 2012 but had probably started years before then.

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

My Parkinson’s “has got nothing to do with God”

Campaigner Hema Reilly on challenging Parkinson’s stigma

Parkinson’s UK to launch largest plant-based oil trial in the world

The trial will be carried out over three years

Peace of mind: your Parkinson’s passport to a more comfortable holiday

‘Parkinson’s passport’ makes travelling easier

New biotech to drive forward GDNF treatment for Parkinson’s disease

UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…

New wearable medical device for Parkinson’s disease to launch this year

The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Ex-France international rugby player has Parkinson’s disease

News

Author: Geoffrey ChangPublished: 23 December 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

My Parkinson’s “has got nothing to do with God”

Advances

Parkinson’s UK to launch largest plant-based oil trial in the world

Resources & Tools

Peace of mind: your Parkinson’s passport to a more comfortable holiday

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Ex-France international rugby player has Parkinson’s disease

News

Author: Geoffrey ChangPublished: 23 December 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

My Parkinson’s “has got nothing to do with God”

Advances

Parkinson’s UK to launch largest plant-based oil trial in the world

Resources & Tools

Peace of mind: your Parkinson’s passport to a more comfortable holiday

New biotech to drive forward GDNF treatment for Parkinson’s disease

New wearable medical device for Parkinson’s disease to launch this year

New study brings scientists a “vital step” closer to understanding Parkinson’s disease

{title}

Subscribe

Sign in